It's almost commical how Aarcor states his opinion as if it's a fact. He knows so little about the potential future of Bioasis, and seems to disregard that the industry is taking notice (see recent Bioasis new releases). He's living in the past.

Bioasis just sold a antibody specific license. This is part of the future, Aarcor, Bioasis selling licenses for upfront money and milestone payments. Bring it on.

Lots of stuff going on, it would seem.

What other deals are in the works?